Literature DB >> 30063868

From thymus to cystic fibrosis: the amazing life of thymosin alpha 1.

Enrico Garaci1.   

Abstract

Entities:  

Year:  2018        PMID： 30063868     DOI： 10.1080/14712598.2018.1484447

Source DB:  PubMed          Journal:  Expert Opin Biol Ther        ISSN： 1471-2598            Impact factor:   4.388


× No keyword cloud information.
  6 in total

1.  Sus Scrofa immune tissues as a new source of bioactive substances for skin wound healing.

Authors:  Alexandr Basov; Liliya Fedulova; Ekaterina Vasilevskaya; Ekaterina Trofimova; Nataliya Murashova; Stepan Dzhimak
Journal:  Saudi J Biol Sci       Date:  2020-12-21       Impact factor: 4.219

2.  Assessment of sarcopenia as a predictor of poor overall survival for advanced non-small-cell lung cancer patients receiving salvage anti-PD-1 immunotherapy.

Authors:  Yixing Wang; Ping Chen; Jinsheng Huang; Minghui Liu; Dingsheng Peng; Zichun Li; Tao Chen; Shaodong Hong; Yixin Zhou
Journal:  Ann Transl Med       Date:  2021-12

3.  HORDB a comprehensive database of peptide hormones.

Authors:  Ning Zhu; Fanyi Dong; Guobang Shi; Xingzhen Lao; Heng Zheng
Journal:  Sci Data       Date:  2022-04-25       Impact factor: 8.501

4.  A Double-blind Multicenter Two-arm Randomized Placebo-controlled Phase-III Clinical Study to Evaluate the Effectiveness and Safety of Thymosin α1 as an Add-on Treatment to Existing Standard of Care Treatment in Moderate-to-severe COVID-19 Patients.

Authors:  Adarsh Shetty; Nirhali Sonali Chandrakant; Rahul Ashok Darnule; B G Manjunath; Prachee Sathe
Journal:  Indian J Crit Care Med       Date:  2022-08

5.  Thymosin α1 for COVID-19: Look before You Leap!

Authors:  Jigeeshu V Divatia
Journal:  Indian J Crit Care Med       Date:  2022-08

Review 6.  Thymic Aging May Be Associated with COVID-19 Pathophysiology in the Elderly.

Authors:  Weikan Wang; Rachel Thomas; Jiyoung Oh; Dong-Ming Su
Journal:  Cells       Date:  2021-03-12       Impact factor: 6.600
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.